换一批Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
第一作者：
S K,Swan
第一单位：
Division of Nephrology, Hennepin County Medical Center and Total Renal Research, Inc., Minneapolis, Minnesota 55415, USA.
作者：
医学主题词
成年人(Adult);中枢神经系统(Central Nervous System);中枢神经系统疾病(Central Nervous System Diseases);造影剂(Contrast Media);双盲法(Double-Blind Method);女(雌)性(Female);钆(Gadolinium);人类(Humans);注射, 静脉内(Injections, Intravenous);肝(Liver);肝疾病(Liver Diseases);磁共振成像(Magnetic Resonance Imaging);男(雄)性(Male);中年人(Middle Aged);有机金属化合物(Organometallic Compounds);肾功能不全(Renal Insufficiency);安全(Safety)
DOI
10.1002/(sici)1522-2586(199902)9:2<317::aid-jmri25>3.0.co;2-b
PMID
10077031
发布时间
2019-09-15
- 浏览20
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
